Novel succinate salt of O-desmethyl-venlafaxine

Details for Australian Patent Application No. 2002250058 (hide)

International Classifications

Event Publications

20 February 2003 Application Open to Public Inspection

Published as AU-B-2002250058

16 August 2007 Application Accepted

Published as AU-B-2002250058

20 December 2007 Standard Patent Sealed

12 February 2009 Extension of Term of Standard Patents

Wyeth The earliest first regulatory approval date provided by the patentee 18 Aug 2008 For the goods ECENZE desvenlafaxine (as succinate)

23 April 2009 Extension of Term of Standard Patents

Wyeth The earliest first regulatory approval date provided by the patentee 18 Aug 2008 For the goods PRISTIQ desvenlafaxine (as succinate) Address for service in Australia: Phillips Ormonde Fitzpatrick Level 22 367 Collins Street Melbourne VIC 3000

6 August 2009 Extension granted

Wyeth The earliest first regulatory approval date provided by the patentee 18 Aug 2008 For the goods PRISTIQ desvenlafaxine (as succinate) Notice of Opposition filed on 22 Jul 2009 by Alphapharm Pty Ltd

25 February 2010 Opposition Withdrawn

The opposition by Alphapharm Pty Ltd against Wyeth has been withdrawn.

13 May 2010 Extension granted

Wyeth The earliest first regulatory approval date provided by the patentee 18 Aug 2008 For the goods PRISTIQ desvenlafaxine (as succinate) Extension of Term of patent pursuant to Section 77 expires on 18 Aug 2023

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.